Kyongbo Pharmaceutical Co., Ltd

₩4,995As of Sun 8 Nov 2026, 12:00 UTC
KRX:214390Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (8.45%)
Div yield 1.00%
ROE 3.49%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.27
PE TTM 23.65
TSR TTM (14.60%)
Mkt cap ₩119.4B
ROIC 0.78%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,842
(3.06%)
(84.78%)
Hold 10|0|3|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
53.95
54.79
61.07
62.22
15.63%
7.09%
24.80%
25.27%
Revenue₩B
8.630
9.061
9.502
9.411
3.92%
5.35%
11.10%
11.28%
Peers (US$88.04M)
Cap (US$)
PE
92.70M
13.42x
79.31M
—
88.22M
17.20x
Capital
TTM
5Y
10Y
Leveragex
1.033
—
—
EBIT/Intx
1.343
0.239
0.239
Own earn%
180.23
(294.85)
(222.12)
Sh yield%
36.09
27.19
28.46
Owners
Insiders/Inst%
11.20
68.34
Short interest%
0.97
SBC / revenue%
0.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
9–13
$1 testx
−0.2
Incr. ROIC%
10